Lipocine
LPCN
#10384
Rank
โ‚ฌ14.56 M
Marketcap
1,77ย โ‚ฌ
Share price
-0.49%
Change (1 day)
-40.07%
Change (1 year)

Market capitalization of Lipocine (LPCN)

Market cap: โ‚ฌ14.56 Million

As of June 2026 Lipocine has a market cap of โ‚ฌ14.56 Million. This makes Lipocine the world's 10384th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lipocine from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ14.56 M-41.06%
2025โ‚ฌ24.71 M1.04%
2024โ‚ฌ24.46 M82.34%
2023โ‚ฌ13.41 M-59.13%
2022โ‚ฌ32.82 M-57.52%
2021โ‚ฌ77.26 M6.39%
2020โ‚ฌ72.62 M461.45%
2019โ‚ฌ12.93 M-47.62%
2018โ‚ฌ24.69 M-59.36%
2017โ‚ฌ60.77 M-4.88%
2016โ‚ฌ63.88 M-70.39%
2015โ‚ฌ0.21 B289.9%
2014โ‚ฌ55.33 M-26.88%
2013โ‚ฌ75.67 M

End of Day market cap according to different sources

On Jun 8th, 2026 the market cap of Lipocine was reported to be:

โ‚ฌ14.56 Million
by Nasdaq info icon info icon
โ‚ฌ14.56 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
โ‚ฌ37.38 B 256,494.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚ฌ12.61 B 86,465.61%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Agile Therapeutics
AGRX
โ‚ฌ9.03 M-38.01%๐Ÿ‡บ๐Ÿ‡ธ USA